Premium
O4–03–02: The gamma secretase inhibitor MK–0752 acutely and significantly reduces CSF Abeta40 concentrations in humans
Author(s) -
Rosen Laura B.,
Stone Julie A.,
Plump Andrew,
Yuan Jinyu,
Harrison Tim,
Flynn Mary,
Dallob Aimee,
Matthews Catherine,
Stevenson Donna,
Schmidt Dennis,
Palmieri Theresa,
Leibowitz Mark,
Jhee Stanford,
Ereshefsky Larry,
Salomon Ronald,
Winchell Greg,
Shearman Mark S.,
Murphy M. Gail,
Gottesdiener Keith M.
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.310
Subject(s) - pharmacokinetics , pharmacodynamics , tolerability , pharmacology , medicine , dosing , drug , placebo , dose–response relationship , adverse effect , alternative medicine , pathology